# Cemex Sab de CV: financial statements, quarterly

CX · NYSE · CIK 1076378 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cx.md) · [Financials](/companies/cx/financials.md) · [Filings](/companies/cx/filings.md) · [Insiders](/companies/cx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-12-31) | period not labelled (2017-12-31) | period not labelled (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001193125-20-126557.md) | [0.7](/filings/0001193125-21-129260.md) | [0.3](/filings/0001193125-22-133730.md) | [0.8](/filings/0001193125-23-128248.md) | [1.0](/filings/0001193125-24-119054.md) | [0.6](/filings/0001193125-25-097693.md) | [0.5](/filings/0001193125-25-097693.md) | [0.6](/filings/0001193125-25-097693.md) | [0.9](/filings/0001193125-25-097693.md) |
| Current assets | $bn | [4.3](/filings/0001193125-20-126557.md) | [3.6](/filings/0001193125-20-126557.md) | [3.4](/filings/0001193125-20-126557.md) | [4.6](/filings/0001193125-21-129260.md) | [4.2](/filings/0001193125-22-133730.md) | [4.2](/filings/0001193125-23-128248.md) | [4.5](/filings/0001193125-24-119054.md) | [5.0](/filings/0001193125-25-097693.md) | [5.0](/filings/0001193125-25-097693.md) |
| Total assets | $bn | [29.8](/filings/0001193125-20-126557.md) | [29.9](/filings/0001193125-20-126557.md) | [29.2](/filings/0001193125-20-126557.md) | [29.4](/filings/0001193125-21-129260.md) | [27.4](/filings/0001193125-22-133730.md) | [26.7](/filings/0001193125-23-128248.md) | [26.4](/filings/0001193125-24-119054.md) | [28.4](/filings/0001193125-25-097693.md) | [27.3](/filings/0001193125-25-097693.md) |
| Current liabilities | $bn | [4.3](/filings/0001193125-20-126557.md) | [5.9](/filings/0001193125-20-126557.md) | [4.8](/filings/0001193125-20-126557.md) | [5.4](/filings/0001193125-21-129260.md) | [5.4](/filings/0001193125-22-133730.md) | [5.4](/filings/0001193125-23-128248.md) | [5.5](/filings/0001193125-24-119054.md) | [6.8](/filings/0001193125-25-097693.md) | [6.1](/filings/0001193125-25-097693.md) |
| Total liabilities | $bn | [20.4](/filings/0001193125-20-126557.md) | [19.3](/filings/0001193125-20-126557.md) | [18.1](/filings/0001193125-20-126557.md) | [18.5](/filings/0001193125-21-129260.md) | [18.5](/filings/0001193125-22-133730.md) | [16.4](/filings/0001193125-23-128248.md) | [15.5](/filings/0001193125-24-119054.md) | [16.3](/filings/0001193125-25-097693.md) | [14.8](/filings/0001193125-25-097693.md) |
| Shareholders' equity | $bn | [9.5](/filings/0001193125-20-126557.md) | [10.6](/filings/0001193125-20-126557.md) | [9.5](/filings/0001193125-20-126557.md) | [9.3](/filings/0001193125-21-129260.md) | [8.1](/filings/0001193125-22-133730.md) | [9.8](/filings/0001193125-23-128248.md) | [10.5](/filings/0001193125-24-119054.md) | [11.8](/filings/0001193125-25-097693.md) | [12.2](/filings/0001193125-25-097693.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 14,507,429,244 at 2025-12-31, from the cover of the [20-F filed 2026-04-24](/filings/0001193125-26-177605.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.